Testosterone: Difference between revisions
From Pharmacopedia
More actions
| [unchecked revision] | [unchecked revision] |
MDElliottMD (talk | contribs) Create Testosterone scaffold |
MDElliottMD (talk | contribs) Sweep: "indications" -> "problems" sitewide terminology update (preserves MedTemplate param name) |
||
| Line 15: | Line 15: | ||
| legal = Schedule III (DEA, US) | | legal = Schedule III (DEA, US) | ||
| mechanism = Endogenous androgen binding to androgen receptors; mediates male secondary sex characteristics, anabolism, libido, erythropoiesis, and CNS effects on mood/energy/aggression. Aromatized peripherally to estradiol; reduced to DHT. | | mechanism = Endogenous androgen binding to androgen receptors; mediates male secondary sex characteristics, anabolism, libido, erythropoiesis, and CNS effects on mood/energy/aggression. Aromatized peripherally to estradiol; reduced to DHT. | ||
| intro = Testosterone is the principal endogenous androgen and the most prescribed hormone therapy in adult men. Delivered through an unusually wide range of formulations because endogenous half-life is short and oral bioavailability of native testosterone is essentially zero. Off-label use for "low T" symptoms in men with normal levels remains controversial; clear | | intro = Testosterone is the principal endogenous androgen and the most prescribed hormone therapy in adult men. Delivered through an unusually wide range of formulations because endogenous half-life is short and oral bioavailability of native testosterone is essentially zero. Off-label use for "low T" symptoms in men with normal levels remains controversial; clear problems are biochemical hypogonadism and gender-affirming care. | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||